What is Opto Circuits (India) share price return in the past 10 years?

Opto Circuits (India) Ltd share price has declined -22.3% annually (CAGR) over the past ten years.

What is the P/E ratio of Opto Circuits (India)?

The latest standalone P/E ratio of Opto Circuits (India) as of 23-May-2022 is 0.00.

What is the P/B ratio of Opto Circuits (India)?

The latest standalone P/B ratio of Opto Circuits (India) as of 23-May-2022 is -0.44.

What is the 52-week high and low of Opto Circuits (India)?

The 52-week high of Opto Circuits (India) is Rs. 1.94 and the 52-week low is Rs. 1.78.

Opto Circuits (India) Ltd - Stock Valuation and Financial Performance

Name: Opto Circuits (India)
Brand: Opto Circuits (India)

BSE: 532391 | NSE: OPTOCIRCUI | Medical Equipment/Supplies/Accessories | Small Cap

Place order

DeciZen - make an informed investing decision on Opto Circuits (I)

Based on:

Data

M-Cap below 100cr DeciZen not available

Opto Circuits (India) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

53.5 Cr.

52-wk low:

1.8

52-wk high:

1.9

Is an attractive stock to invest in?

1. Is a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Opto Circuits (India) Ltd is a below average quality company.

2. Is undervalued or overvalued?

The key valuation ratios of Opto Circuits (India) Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Opto Circuits (I):

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	TTM
ROCE % ⓘ	19.2%	15%	12.9%	4.5%	-6.3%	0.7%	-19.9%	0.7%	2.1%	-106.6%	-
Value Creation Index ⓘ	0.4	0.1	-0.1	-0.7	-1.5	-1.0	-2.4	-1.0	-0.9	-8.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	603	670	699	263	146	76.7	50.4	63.5	105	62.6	0
Sales YoY Gr.	-	11%	4.4%	-62.4%	-44.4%	-47.5%	-34.3%	26%	65.2%	-40.3%	-
Adj EPS ⓘ	9.8	9.7	10	1.8	-2.9	-0.7	-15	0.3	1.1	-11.6	-5.3
YoY Gr.	-	-1.4%	3.7%	-82.1%	-263.7%	NA	NA	NA	220.6%	-1163.3%	-
BVPS (₹) ⓘ	43.9	50.1	60	61.8	53	52.3	36.8	39.1	39.1	1.3	-4
Adj Net Profit ⓘ	238	234	243	43.3	-70.9	-18	-364	9.8	32.7	-349	-159
Cash Flow from Ops. ⓘ	118	-29.5	-92.9	-15.7	55.7	335	57.4	46.6	42	21.3	-
Debt/CF from Ops. ⓘ	6.1	-22.3	-8.8	-56	15.9	2.1	12.4	11.8	12.6	23	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-22.3%	-15.6%	7.5%	-40.3%
Adj EPS ⓘ	-201.9%	NA	NA	-1163.3%
BVPSⓘ	-32.4%	-52.4%	-67.2%	-96.7%
Share Price	-22.3%	-13.3%	-16%	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	TTM
Return on Equity % ⓘ	24.7	20.6	18.2	2.9	-5.1	-1.4	-33.7	1	2.8	-57.4	389.7
Op. Profit Mgn % ⓘ	40	41.7	39.4	43.7	36.5	30.6	29.8	31.8	39.8	26.9	-4905.1
Net Profit Mgn % ⓘ	39.4	35	34.7	16.5	-48.5	-23.5	-722.8	15.5	31.2	-556.7	-63493.1
Debt to Equity ⓘ	0.7	0.5	0.6	0.6	0.7	0.6	0.8	0.5	0.5	12.5	-
Working Cap Days ⓘ	375	609	906	2,774	4,958	8,646	10,239	6,471	3,949	4,624	62,800
Cash Conv. Cycle ⓘ	234	264	360	1,308	2,330	2,263	734	401	3	-122	-5,29,655

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Opto Circuits (India) Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-5.3	-4.3
TTM Sales (₹ Cr.)	0.3	106
BVPS (₹.) ⓘ	-4	-7.7
Reserves (₹ Cr.) ⓘ	-421	-531
P/BV ⓘ	-0.44	-0.23
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	1.78 / 1.94
All Time Low / High (₹)	1.45 / 262.90
Market Cap (₹ Cr.)	53.5
Equity (₹ Cr.)	300.6
Face Value (₹)	10
Industry PE ⓘ	78.3

Management X-Ray of Opto Circuits (I):

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Opto Circuits (I)

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Opto Circuits (I)

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Sales	603.20	669.74	699.25	262.78	146.14	76.67	50.38	63.46	104.82	62.61
Operating Expenses ⓘ	361.70	390.40	425.79	149.55	98.05	53.22	35.38	43.28	63.10	45.80
Manufacturing Costs	6.30	4.24	9.24	9.14	9.83	6.52	3.90	2.80	2.98	2.51
Material Costs	337.59	363.56	391.91	119.43	64.18	28.02	16.04	25.06	40.29	25.09
Employee Cost	6.64	8.25	9.53	9.95	10.07	9.78	8.21	7.66	9.41	9.04
Other Costs ⓘ	11.18	14.35	15.11	11.03	13.96	8.90	7.23	7.76	10.42	9.16
Operating Profit ⓘ	241.50	279.34	273.46	113.23	48.09	23.46	15	20.18	41.72	16.81
Operating Profit Margin (%)	40.0%	41.7%	39.1%	43.1%	32.9%	30.6%	29.8%	31.8%	39.8%	26.8%
Other Income ⓘ	36.39	1.34	0.03	0	0.01	0	0.17	0.25	3.16	2.94
Interest ⓘ	24.93	36.65	22	53.58	57.82	31.52	7.85	1.36	1.15	0.85
Depreciation ⓘ	5.91	6.05	6.61	7.92	9.73	9.50	8.79	9.06	8.81	3.26
Exceptional Items ⓘ	0	0	0	0	-181.40	0	-362.57	0	0	-1,207.16
Profit Before Tax ⓘ	247.05	237.97	244.87	51.73	-200.84	-17.55	-364.04	10.01	34.92	-1,191.52
Tax ⓘ	2.68	3.21	3.83	9.57	0.67	0.47	0	0	0	0
Profit After Tax	244.38	234.77	241.04	42.16	-201.51	-18.02	-364.04	10.01	34.92	-1,191.52
PAT Margin (%)	40.5%	35.1%	34.5%	16.0%	-137.0%	-23.5%	-722.0%	15.8%	33.3%	-1,903.0%
Adjusted EPS (₹)	10.1	9.7	10.0	1.7	-8.3	-0.7	-15.0	0.4	1.2	-39.6
Dividend Payout Ratio (%)	34%	31%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Equity and Liabilities
Shareholders Fund	1,062.83	1,213.11	1,454.15	1,496.31	1,284.99	1,266.97	892.32	1,123.31	1,176.50	39.02
Share Capital ⓘ	186.40	242.32	242.32	242.32	242.32	242.32	242.32	287.50	300.63	300.63
Reserves ⓘ	876.43	970.79	1,211.83	1,253.99	1,042.67	1,024.65	650	835.81	875.87	-261.60
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	716.78	649.25	800.79	871.41	872.95	701.79	705.95	541.14	522.11	488.89
Long Term Debt	148.13	8	0.01	7.75	3.88	51.61	52.90	104.77	101.30	30.61
Short Term Debt	568.65	641.24	800.78	863.66	869.07	650.18	653.04	436.37	420.81	458.27
Trade Payables	6.68	12.13	55.42	37.23	117.78	140.25	7.62	20.06	31.92	54.46
Others Liabilities ⓘ	257.29	130.80	164.41	118.41	148.15	149.34	96.12	89.93	93.30	61.49
Total Liabilities ⓘ	2,043.59	2,005.28	2,474.77	2,523.35	2,423.86	2,258.35	1,702.02	1,774.43	1,823.83	643.85
Fixed Assets
Gross Block	98.66	99.30	152.22	152.44	151.81	147.55	148.97	149.19	149.03	44.88
Accumulated Depreciation	19.37	25.40	31.32	39.24	56.89	62.56	71.36	80.42	88.92	32.66
Net Fixed Assetsⓘ	79.29	73.90	120.90	113.20	94.91	84.98	77.61	68.77	60.11	12.22
CWIP ⓘ	1.20	1.28	1.29	1.29	0	102.10	102.17	157.44	157.94	0
Investmentsⓘ	1,114.39	381.66	381.66	381.66	381.66	381.66	381.66	436.57	447.04	202.36
Inventories	245.21	265.45	360.53	438.87	341.65	280.99	108.04	27.02	26.18	17.23
Trade Receivables	228.78	257.33	584.26	615.01	646	0.80	5.38	12.08	23.32	23.78
Cash Equivalents	117.46	45.60	2.16	2.31	1.76	2.76	0.78	0.97	1.21	0.31
Others Assetsⓘ	257.25	980.06	1,023.96	971.02	957.88	1,405.04	1,026.37	1,071.58	1,108.03	387.96
Total Assets ⓘ	2,043.59	2,005.28	2,474.77	2,523.35	2,423.86	2,258.35	1,702.02	1,774.43	1,823.83	643.85

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Cash Flow From Operating Activity ⓘ	118.02	-29.50	-92.94	-15.73	55.68	334.73	57.36	46.58	41.96	21.30
PBT ⓘ	247.05	237.97	244.87	51.73	-200.84	-18.02	-364.04	10.01	34.92	-1,191.52
Adjustment ⓘ	6.31	42.42	28.59	61.32	67.72	42.81	271.60	10.42	8.54	1,211.11
Changes in Working Capital ⓘ	-132.66	-306.69	-362.57	-119.21	189.48	309.94	149.81	26.16	-1.5	1.72
Tax Paid ⓘ	-2.68	-3.21	-3.83	-9.57	-0.67	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	-572.02	145.70	-19.18	-0.22	0.04	-48.80	-55.65	-0.77	-11.42	18.96
Capex	-4.82	-0.75	-53.67	-0.22	0.04	-103.47	-1.49	-0.22	-0.07	-0.03
Net Investments	-592.96	146.06	34.47	0	0	0	0	0	0	0
Others ⓘ	25.75	0.39	0.02	0	0	54.67	-54.16	-0.55	-11.35	18.99
Cash Flow From Financing Activityⓘ	460.63	-188.07	68.68	16.09	-56.28	-284.93	-3.69	-45.63	-30.29	-41.17
Net Proceeds from Shares ⓘ	79.69	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-24.93	-36.65	-22	-53.58	-57.82	-31.52	-7.85	-1.36	-1.15	-0.85
Dividend Paid ⓘ	-91.74	-83.88	-60.86	-0.94	0	0	0	0	0	0
Others ⓘ	497.61	-67.53	151.54	70.62	1.54	-253.41	4.16	-44.27	-29.15	-40.32
Net Cash Flow ⓘ	6.63	-71.87	-43.44	0.15	-0.55	1	-1.98	0.18	0.24	-0.90

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Ratios
ROE (%)	25.75	20.63	18.07	2.86	-14.49	-1.41	-33.72	0.99	3.04	-196.05
ROCE (%)	19.15	15.02	12.9	4.53	-6.29	0.67	-19.88	0.69	2.14	-106.58
Asset Turnover Ratio	0.37	0.33	0.31	0.11	0.06	0.03	0.03	0.04	0.06	0.05
PAT to CFO Conversion(x)	0.48	-0.13	-0.39	-0.37	N/A	N/A	N/A	4.65	1.2	N/A
Working Capital Days
Receivable Days	129	132	220	833	1,575	1,540	22	50	62	137
Inventory Days	109	139	163	555	975	1,482	1,409	388	93	127
Payable Days	5	8	25	101	330	1,521	1,682	202	235	628

Opto Circuits (India) Ltd Stock News

Opto Circuits (India) Ltd FAQs

What is the share price of Opto Circuits (I)?

Company share prices are keep on changing according to the market conditions. The closing price of Opto Circuits (I) on 23-May-2022 18:01 is ₹1.78.

What is the market cap of Opto Circuits (I)?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-May-2022 18:01 the market cap of Opto Circuits (I) stood at ₹53.51.

What is the P/E ratio of Opto Circuits (I)?

The latest P/E ratio of Opto Circuits (I) as of 23-May-2022 18:01 is 0.00.

What is the P/B ratio of Opto Circuits (I)?

The latest P/B ratio of Opto Circuits (I) as of 23-May-2022 18:01 is -0.44.

What is the 52-week high and low of Opto Circuits (I)?

The 52-week high of Opto Circuits (I) is ₹1.94 and the 52-week low is ₹1.78.

What is the TTM revenue of Opto Circuits (I)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Opto Circuits (I) is ₹0.25 ( Cr.) .

About Opto Circuits (India) Ltd

Opto Circuits India (OCI), incorporated in the year 1992 is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries. The manufacturing is backed by a complete range of inspection and reliability testing equipments such as Bond Pull, Shear Testers, Stereo Microscopes, IR Viewers Spectrometers and many more.

OCI specialize in cardiac and vital signs monitoring, emergency cardiac care, vascular treatments and sensing technologies. Its products are US FDA listed and CE marked. Some of the well-known brands marketed by the company are Criticare Systems, Mediaid, Unetixs Vascular, Eurocor and Cardiac Science.

The company has customers in USA, Europe, Middle East, Far East, South Africa etc. To service these customers it has offices through its subsidiaries in USA, Germany, Singapore and Dubai. It has subsidiaries namely Mediaid Inc (USA), Eurocor Gmbh (Germany), Criticare Systems Inc (USA), Advanced Micronic Devices (India), Devon Innovations (India), ORMED Medical Technology (India) and Altron Industries (India).

It clients includes names like Manipal Groups of hospitals, Escorts Heart Hospital, Wockhardt Heart Hospitals, Apollo Group of Hospitals, Lilavati hospital, Breach Candy Hospital are among others.

In January 2009, the companyâ€™s California-based Mediaid Inc., the subsidiary company and the international marketing arm of the company had received Brazilian FDA agency - Agencia Nacional de Vigilancia Sanitaria (ANVISA) - approval for marketing and sale of the Mediaid brand of US FDA-approved Pulse Oximetry (SPO2) products (Patient Monitors & Sensors) in the country and surrounding geographies.

During December, 2010 Opto Circuits (India) has successfully acquired 76% of outstanding common stock of Cardiac Science Corporation US. The company plans to exercise its top-up option under the terms of the merger agreement. The merger is expected to occur in the next few days. Following the merger, Cardiac Science will become a wholly-owned subsidiary of Opto Circuits (India).

Products

Health Care products- Under this segment it manufactures Pulse Oximeters, Pulse Oximeter Sensors, Fluid warmers, Digital Thermometer,Cholesterol Monitors And Stent.

Opto Electronics products- The Company manufactures Infrared Emitters, Infra Red Detectors, Photo Sensor, Detector and Emitter Assemblies.

Recognition

The company has ISO 9001-2000 and ISO 13485-2003 quality system certification.

OCI has received 2 Star Trading House Status in accordance with the provisions of Exim Policy of Federal Government of India.

Opto Circuits (India) has been featured in Forbes Asiaâ€™s 200 â€˜Best Under a Billionâ€™ List, 2011 by Forbes magazine. This is the third time the company has made it to this list, the last two times being 2008 and 2009.

Milestones

2010
- Opto Circuits acquisition of Unetixs Vascular creates strong synergies for Criticare Systems.
- Opto Circuits Successfully Completes Acquisition of Cardiac Science.
- Opto Circuits forays into manufacturing of cardiac stents - acquires Kolkata based N.S. Remedies.

2011
- Opto Circuits presents Bangalore Metro Rail Corporation Ltd. it's first public access defibrillator.
- Opto Circuits launches campaign to promote heart safe environments on World Heart Day.
- Opto Circuits ranked amongst Forbes' Asia's 200 Best Under a Billion companies for third year.

2012
- Opto Circuits launches new Powerheart G5 AED.
- Opto Circuits Supplies AEDs to 2012 UEFA European Football Championship.
- Opto Circuits launches its first Sirolimus Drug Eluting Stent."